Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › insulin aspart

insulin aspart

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of insulin aspart

60 trials tracked of insulin aspart: 51 in phase 3 or 4 and 20 with published results. The most-cited published study has 207 citations.

60Trials tracked
51Phase 3 & 4
0Recruiting
20With published results
Phase distribution
Phase 4 15 Phase 3 36 Phase 2 6 Phase 1 3
  1. Phase 3 A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes Completed · 207 cited
  2. Phase 3 A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus Completed · 187 cited
  3. Phase 3 Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes Completed · 176 cited
  4. Phase 3 A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4) Completed · 134 cited
  5. Phase 3 Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Completed · 119 cited
  6. Phase 3 A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6) Completed · 100 cited
Show 44 more trials
  1. Phase 3 Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes Completed · 77 cited
  2. Phase 3 A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes Completed · 73 cited
  3. Phase 3 Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes Completed · 67 cited
  4. Phase 3 Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes Completed · 54 cited
  5. Phase 4 The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study Completed · 53 cited
  6. Phase 3 Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes Completed · 48 cited
  7. Phase 3 A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification Completed · 40 cited
  8. Phase 3 Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes Completed · 26 cited
  9. Phase 3 Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients Completed · 17 cited
  10. Phase 4 Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes Completed · 10 cited
  11. Phase 4 A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients Completed · 8 cited
  12. Phase 3 Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine Completed · 6 cited
  13. Phase 4 Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D Completed · 3 cited
  14. Phase 3 Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Completed · 3 cited
  15. Phase 4 Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids Completed
  16. Phase 4 The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children Completed
  17. Phase 4 Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes Completed
  18. Phase 4 CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) Completed
  19. Phase 4 Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen Completed
  20. Phase 4 Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus Completed
  21. Phase 4 Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. Completed
  22. Phase 4 Comparison of Insulins Aspart and Lispro in Insulin Pumps Completed
  23. Phase 4 Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase Completed
  24. Phase 4 Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial Completed
  25. Phase 4 Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs Completed
  26. Phase 3 A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification Completed
  27. Phase 3 A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes Completed
  28. Phase 3 IDegLira HIGH Trial Completed
  29. Phase 3 Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes Completed
  30. Phase 3 Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes Completed
  31. Phase 3 Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689 Completed
  32. Phase 3 Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes Completed
  33. Phase 3 Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin Completed
  34. Phase 3 Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes Completed
  35. Phase 3 A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily Completed
  36. Phase 3 Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes Completed
  37. Phase 3 Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes Completed
  38. Phase 3 A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus Completed
  39. Phase 3 Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes Completed
  40. Phase 3 Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes Completed
  41. Phase 3 Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy Completed
  42. Phase 3 A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus Completed
  43. Phase 3 Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes Completed
  44. Phase 3 Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes Completed

Showing the 50 most-cited and recently-updated of 60 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review finds no difference in hypoglycemia or ketoacidosis between insulin types
Diabetes & Endocrinology Meta-analysis
Systematic review finds no difference in hypoglycemia or ketoacidosis between insulin types Children on insulin may not need newer expensive versions
A meta-analysis of 1,107 children with type 1 diabetes found no significant difference in severe hypoglycemia, ketoacidosis, or serious adve…
A major review finds older human insulin works as safely as newer analogues for children with type 1 diabetes, which could ease costs for fa…
May 15, 2026
Insulin dose reduction during exercise yields similar glucose effects with ultra-rapid and rapid aspart
Diabetes & Endocrinology RCT
Insulin dose reduction during exercise yields similar glucose effects with ultra-rapid and rapid aspart When exercising with type 1 diabetes, does the type of fast-acting insulin matter?
A laboratory-controlled RCT in 43 adults with type 1 diabetes found similar blood glucose declines during exercise with 50-75% reduced doses…
For people with type 1 diabetes, cutting your pre-workout insulin dose by half or three-quarters matters more than choosing between ultra-ra…
Apr 5, 2026